GMP Cell Banking Services Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2031 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa)

The global GMP cell banking services market is witnessing significant growth, with the mammalian cell type segment taking the lead in terms of revenue and attractiveness. This trend is projected to continue throughout the forecast period, highlighting the pivotal role of mammalian cell banking services in the biopharmaceutical industry.

Mammalian Segment Dominates and Continues to Thrive

The mammalian cell type segment has asserted its dominance in the global GMP cell banking services market, contributing to over 60% of the total revenue share. This segment's attractiveness is evident with an attractiveness index of 5, indicating its strong potential over the forecast period. By 2031, the mammalian segment is expected to further solidify its position by gaining 556 basis points in market share and achieving remarkable growth, set to increase by 3.2 times.

Driving Factors

Limited in-house storage and testing capabilities have emerged as a primary driver for the global GMP cell banking services market. Global biopharmaceutical companies are increasingly turning to outsourcing as they seek to enhance operational efficiency and boost pipeline productivity. Small biotechnology firms, backed by venture capital and larger biopharmaceutical companies, are at the forefront of discovering promising new therapies. These organizations continue to invest in their pipelines, bolstered by ongoing funding availability.

Biopharmaceutical companies often prefer to outsource manufacturing activities in regions where they lack expertise, particularly in the later stages of the value chain. Collaborating with Contract Development and Manufacturing Organizations (CDMOs) grants them access to extensive distribution networks and knowledge of regulatory guidelines, driving market growth.

Moreover, large biopharmaceutical companies with multiple manufacturing sites face limitations in in-house storage of GMP cell banks. Cell banking service providers offer dedicated infrastructure, including clean rooms and expert personnel, ensuring compliance with regulatory standards such as ICH. They also provide in-house testing services or subcontract to certified laboratories, further propelling the global GMP cell banking services market.

Regional Dominance of Mammalian Cell Type Segment

• North America: The mammalian cell type segment has established its dominance in the North America GMP cell banking services market in terms of revenue and is poised to maintain this position throughout the forecast period. With an attractiveness index of 5.1, it remains the most attractive segment in the region.
• Latin America: In the Latin America GMP cell banking services market, the mammalian segment also takes the lead with an attractiveness index of 4.5, underscoring its significance in the regional landscape.
• Europe: Revenue from the mammalian segment in the Europe GMP cell banking services market is expected to surpass US$ 200 million by 2031, highlighting its robust growth trajectory.
• Asia Pacific: The mammalian segment continues to dominate the Asia Pacific GMP cell banking services market, further strengthening its position.

The global GMP cell banking services market is witnessing a significant shift, with the mammalian cell type segment emerging as a key driver of growth and innovation in the biopharmaceutical industry.

Market Segmentation

By Cell Type

• Mammalian
• Microbial
• Insect
• Yeast
• Avian
• Stem Cell
• Others

By End User

• Biopharmaceutical Companies
• Contract Manufacturing Organizations

By Region

• North America
• Latin America
• Europe
• Asia Pacific
• MEA

This product will be delivered within 1-3 business days.